Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000988521 | SCV001138269 | uncertain significance | Drash syndrome | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001861942 | SCV002216364 | uncertain significance | Drash syndrome; Frasier syndrome; Wilms tumor 1; 11p partial monosomy syndrome | 2021-09-26 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 584764). This missense change has been observed in individual(s) with premature ovarian failure (PMID: 26358501). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This sequence change replaces proline with serine at codon 126 of the WT1 protein (p.Pro126Ser). The proline residue is moderately conserved and there is a moderate physicochemical difference between proline and serine. |
All of Us Research Program, |
RCV003999794 | SCV004821045 | uncertain significance | Wilms tumor 1 | 2023-03-28 | criteria provided, single submitter | clinical testing |